Introduction: The impact of bleeding for women with bleeding disorders (WBD) is of increasing focus and importance. Despite this, optimal management strategies are unclear and knowledge gaps persist.
Aim: To examine practices and define research priorities on diagnosis and management of WBD in Europe.
Objective: This study sought to assess whether the association between statin use and bone mineral density (BMD) and bone turnover markers is modulated by serum 25-hydroxyvitamin D (25OHD) levels in postmenopausal women. Design, Participants, and Settings: Approximately 1422 postmenopausal women were recruited from the Camargo Cohort after excluding those with any known medical disorder or drug that might affect bone metabolism. Participants were categorized into four groups: 25OHD levels of 20 ng/mL or less and not taking statins (group 1; n = 492); 25OHD levels greater than 20 ng/mL and on statins (group 2; n = 143); 25OHD levels of 20 ng/mL or less and using statins (group 3; n = 112); and 2OHD levels greater than 20 ng/mL and non-statin use (group 4; n = 675).
View Article and Find Full Text PDFWe studied 2,315 subjects (1,422 women and 893 men) from the Camargo Cohort and analyzed the differences in BMD between statin or non-statin users. We also studied effects of the type of statin, dose, pharmacokinetic properties, and length of treatment on bone mineral density (BMD). Of the subjects, 478 (21 %) were taking statins (256 women and 222 men).
View Article and Find Full Text PDFObjective: To analyze the effects of statin use on bone turnover markers (BTM), in participants from a large population-based cohort.
Subjects And Methods: Cross-sectional study that included 2431 subjects (1401 women and 930 men) from the Camargo Cohort. We analyzed the differences in serum BTM between statin or non-statin users, by means of a generalized linear model, adjusted for a wide set of covariates and stratified by diabetes status.
The authors appreciate the prevalence of drepanocytosis in a supposed healthy group of blood donors at the Transfusion Center. They propose to carry out a systematic detection of the various hemoglobin types existing in the isle at all stages of active-life: birth, school-time, prenatal consultations, controls for enrolment in the army, etc. They describe the action of the "mother and child protection service" which could develop information and genetic advice to try to limit the dissemination of the drepanocytic tract as well as to avoid the birth of homozygotes.
View Article and Find Full Text PDF